期刊文献+

卡维地络对不稳定型心绞痛血管内皮功能的影响

Effects of carvedilol on endothelium vasoactive substances in patients with unstable angina
下载PDF
导出
摘要 目的观察卡维地络对不稳定型心绞痛(UAP)患者内皮素(ET)、一氧化氮(NO)、降钙素基因相关肽(CGRP)的影响。方法74例UAP患者随机分为常规治疗组34例、卡维地络治疗组40例,20例健康体检者作为正常对照组,观察用药前后血ET、NO和CGRP浓度的变化。结果UAP患者NO和CGRP浓度明显低于正常对照组(P<0·01),而ET浓度明显高于正常对照组(P<0·01)。卡维地络组患者用药后与常规治疗组比较,ET水平降低,NO和CGRP水平升高,差异有统计学意义(P<0·01)。常规治疗组与卡维地络治疗组治疗后血NO、CGRP浓度均较治疗前显著升高(P<0·01),常规治疗组治疗前后血ET浓度无显著性变化(P>0·05),而卡维地络治疗组血ET浓度显著下降(P<0·01)。结论卡维地络能改善不稳定型心绞痛的内皮功能。 Objective To observe the effect of carvedilol on circulating levels of endothelin (ET) and nitric oxide (NO) and Calcitonin gene-related peptide (CGRP) in patients with unstable angina pectoris(UAP).Methods 74 patients with UAP were randomly divided into two groups:normal treatment group (n=34) and carvedilol group (n = 40),20 heathy individuals were control groups. Before and after treatment, the circulating levels of ET.NO and CGRP were observed in patients with UAP and healthy individuals. Results The levels of circulating NO and CGRP in patients with UAP were significantly lower than healthy individuals ( P 〈 0.01) while the level of circulating ET was higher than healthy individuals ( P 〈 0.01 ). After treatment the level of circulating ET in carvedilol group was lower than normal treatment group while the levels of circulating NO and CGRP level were higher than normal treatment group ( P 〈 0.01 ). Both of two groups, the levels of circulating NO and CGRP were significantly higher than those before treatment ( P 〈 0.01) .There was no obvious lowness in the levels of circulating ET after normal treatment ( P 〉 0.05) execpt after earvedilol treatment ( P 〈 0.01 ). Conclusion Carvedilol can do well to the endothelial function in patients with unstable angina.
出处 《广西医学》 CAS 2006年第9期1364-1366,共3页 Guangxi Medical Journal
关键词 卡维地络 心绞痛 血管内皮功能 Carvedilol Unstable angina pectoris Vascular endothelial function
  • 相关文献

参考文献4

  • 1Bogaty P,Hackett D,Davies G,et al.Vasoreactivity of the culprit lesion in unstable angina[J].Circulation,1994,90(1):5 ~ 11.
  • 2Pekdemir H,Cicek D,Camsari A,et al.The relationship between plasma endothelin-1,nitric oxide levels,and heart rate variability in patients With coronary Slow flow[J].Ann Noninvasive Electrocardiol,2004,22 (9):1840~1843.
  • 3Krum H.Sympathetic activation and the role of beta-blockres in chronic heart failure Aust[J].N Z J Med,1999,29(3):418 ~427.
  • 4苏显明,崔长琮,王东琦.卡维地洛对冠状动脉成形术后患者外周血内皮素及一氧化氮的影响[J].中国动脉硬化杂志,2004,12(5):599-601. 被引量:4

二级参考文献12

  • 1Anderson VH, Smalling RW, Serruys PW. Mechanical devices. In:Willerson JT and Cohn JT. Cardiovascular Medicine. New York, Edinburgh, London: Churchill livingstone, 1995; 617-651
  • 2Yue TL,Mckenna PL,Cheng HY, Ruffolo RR, Feuerstein GZ. Carvedilol, a new antihyperensive agent, prevents oxidative injury to endothelial cells. Hypertension, 1993, 22 (12): 922-928
  • 3Ameli S, Kaul S, Castro L, Gemade J. Effect of percutaneous transluminal coronary angioplasty on circulating endothelin level. Am J Cardiol, 1993, 72 (10): 1 352-356
  • 4Cooke JP. Temporature-guided radiotrequency cather ablation with very large distal electrodes. Circulation, 1993, 88 (6): 245-250
  • 5Doaglas SA, Ohlstein EH. Endothelin-1 promotes neointima formation after blloon angioplasty in the rat. J Cardiovasc Pharmacol, 1993, 22 (Sl 8): S 371-375
  • 6Kurosaki K, Ikeda U, Maeda Y, Kogulkin G, Louna P. Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes. J Mol Cell Cardiol, 2000, 32 (3): 333-339
  • 7Ohistein EH,Douglas SA, Sung CP, Wechiten LH. Carvedilol, a cardiovascular drug prevents vascular smooth muscle cell proliferation, migtation, and neointimal formation following vascular injury. Proc Natl Acad Sci USA, 1993, 90 (7): 6 189-193
  • 8Douglas SA, Vickery-Clark LM, Louden C, Ohistein EH, Sung CP. Acute pretreatment with carvedilol is sufficient for inhibition of neointima formation following rat carotid artery balloon angioplasty. Pharmacol Commun, 1994, 5 (1): 65-72
  • 9Ruffolo RR, Gellai M, Hieble JP. The pharmacology of carvedilol. Eur J Clin Pharmacol, 1990, 38 (Sl 2):82-88
  • 10李亚俊,宋剑南,周瑕菁,牛晓红,王宇辉,金红,王少君.脂泰胶囊对实验性动脉粥样硬化家兔内皮素及一氧化氮合酶基因表达的影响[J].中国动脉硬化杂志,1999,7(1):4-8. 被引量:36

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部